Home/ Supplements/ Vitamin K/ Vitamin K2 100 mcg

Vitamin K2 100 mcg

product on market Capsule Bluebonnet Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 100% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · grounded in 1 source · methodology

Vitamin K2 plays a key role in supporting bone health and cardiovascular function by regulating calcium deposition. There is moderate to strong evidence that it works synergistically with Vitamin D to maintain bone density. This specific formulation provides a standard dose of 100 mcg to support these physiological processes.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Vitamin K2 100 mcg
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Capsule(s)
Serving Size
100
Servings
Vitamin
Product Type
100%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

100 mcg
Within RDA (0.8× RDA) 275 studies (A:9, B:175)

Other Ingredients

Cellulose Hypromellose Water, Purified Magnesium Stearate
Claims

Label Claims — Verification

Unverified Nutrient
Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Directions: As a dietary supplement, take one capsule daily, preferably with a meal or as directed by a healthcare practitioner.

Warnings & Precautions

Caution: Do not use this product if you are pregnant, trying to conceive or breastfeeding. If you are taking prescription medication, speak to your healthcare practitioner before use. Do not use this medication with blood thinning medication.

Keep out of reach of children.

Formulation Notes

Bluebonnet's Vitamin K2 100 mcg vegetable capsules are formulated with vitamin K2 (menaquinone-7) produced from fermentation Bacillus subtilis natto cultures to help support strong, healthy bones and heart health.

Free of milk, egg, fish, crustacean shellfish, tree nuts, peanuts, wheat, soybeans and sesame. Also free of gluten, barley, rice, sodium and sugar.

Bluebonnet's KOF-K Certification #K-0000700

Bone & heart health

Vegan

Made with Non GMO ingredients Gluten free Soy free

K Parve (Kosher)

Additional Information

Made with Non GMO Ingredients

K Parve (Kosher)

Store tightly closed in a cool, dry place.

Metadata

Product Details

UPC / SKU7 43715 00653 9
DSLD Entry Date2024-09-25
Product TypeVitamin
FormCapsule
DSLD ID315060
Data Updated2026-04-11
Research

Research Evidence

332
Research Sources
59
Avg Quality
220
Meta Analysis
56
Systematic Review
30
Rct
16
Clinical Trial
3
Guideline
3
Regulatory Source
1
Narrative Review
1
Other
1
Openfda Safety
A Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2017 PubMed DOI
A Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Direct factor Xa inhibitors versus low molecular weight heparins or vitamin K antagonists for prevention of venous thromboembolism in elective primary hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2025 PubMed DOI
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Antiplatelet agents and anticoagulants for hypertension
Systematic Review The Cochrane database of systematic reviews 2022 PubMed DOI
A Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy
Meta Analysis The Cochrane database of systematic reviews 2012 PubMed DOI
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2013 PubMed DOI
A Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
View all evidence for Vitamin K →
Compare

Similar Products

View all Vitamin K products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.